Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

This week, this drug is getting some attention, and that's because former Republican Senator Ben Sass telling the New York Times that he's been taking an experimental drug to treat the stage 4 pancreatic cancer that he was diagnosed with late last year. And he called that at the time a death sentence. And now he's bringing attention to this diagnosis.So, pancreatic cancer has the lowest 5-year survival rate of any major cancer. That's just 13%. And that number really hasn't moved despite advances in other c ...